APA (7th ed.) Citation

Gu, X., Huo, J., Yu, Z., Jiang, J., Xu, Y., & Zhao, L. (2024). Immunotherapy in hepatocellular carcinoma: An overview of immune checkpoint inhibitors, drug resistance, and adverse effects. Oncologie (De Gruyter), 26(1), 9. https://doi.org/10.1515/oncologie-2023-0412

Chicago Style (17th ed.) Citation

Gu, Xuan-Yu, Jin-Long Huo, Zhi-Yong Yu, Ji-Chang Jiang, Ya-Xuan Xu, and Li-Jin Zhao. "Immunotherapy in Hepatocellular Carcinoma: An Overview of Immune Checkpoint Inhibitors, Drug Resistance, and Adverse Effects." Oncologie (De Gruyter) 26, no. 1 (2024): 9. https://doi.org/10.1515/oncologie-2023-0412.

MLA (9th ed.) Citation

Gu, Xuan-Yu, et al. "Immunotherapy in Hepatocellular Carcinoma: An Overview of Immune Checkpoint Inhibitors, Drug Resistance, and Adverse Effects." Oncologie (De Gruyter), vol. 26, no. 1, 2024, p. 9, https://doi.org/10.1515/oncologie-2023-0412.